Search

everythinglearnresearchcommunity

for

Search:↓

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Poor sleep, physical health, depression, and anxiety can worsen urinary problems in men.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Children with partial biotinidase deficiency are healthy at birth but may develop symptoms that improve with biotin therapy.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Biotin deficiency in patients on total parenteral nutrition can cause serious symptoms but can be treated with biotin supplements.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Higher fluoride levels may delay puberty in boys.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.